Resistance to antiretroviral drugs used to treat HIV is an important and evolving concern,
particularly in low-and middle-income countries (LMICs) which have been impacted to the …

Introduction Several low‐and middle‐income countries (LMICs) are preparing to introduce
long‐acting pre‐exposure prophylaxis (LAP). Amid multiple pre‐exposure prophylaxis …

Differentiated service delivery and new products, such as long-acting injectable cabotegravir
(CAB-LA) and the dapivirine vaginal ring (DVR), could increase uptake and use of pre …

Introduction The proven effectiveness of injectable cabotegravir (CAB‐LA) is higher than that
of any other HIV prevention intervention ever trialled or implemented, surpassing medical …

Despite expanded antiretroviral therapy (ART) in South Africa, HIV-1 transmission persists.
Integrase strand transfer inhibitors (INSTI) and long-acting injectables offer potential for …

Background Post-exposure prophylaxis (PEP) offers protection from HIV after condomless
sex, but is not widely available in a timely manner in east, central, southern, and west Africa …

Abstract Purpose of Review Big Data Science can be used to pragmatically guide the
allocation of resources within the context of national HIV programs and inform priorities for …

Community-based active case finding (ACF) for tuberculosis (TB) involves an offer of
screening to populations at risk of TB, oftentimes with additional health promotion …

Pre-exposure prophylaxis (PrEP) has revolutionized the human immunodeficiency virus
(HIV) prevention strategy during the past 15 years. Despite of the fact that people living with …

Pre-exposure prophylaxis (PrEP) is a pivotal intervention among HIV prevention strategies.
We aimed to narratively revise the topic of HIV acute infection in the setting of PrEP …